Venn Life Sciences: Open Orphan secures new two-year contract with German client
Pharmaceutical services company Open Orphan announced a new two-year contract with an unnamed tier 1 Germany-based pharmaceutical company on Friday.
Read full article »
Venn Life Sciences provides consulting and clinical trial services to pharmaceutical, biotechnology and medical device organisations.
Read more